Literature DB >> 19669429

Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival.

K A Staats1, L Van Den Bosch.   

Abstract

Selective motor neuron death during amyotrophic lateral sclerosis (ALS) is a non-cell autonomous process in which non-neuronal cells induce and/or contribute to the disease process. The non-neuronal cells that are clearly involved in the pathogenesis of the disease are the surrounding astrocytes. Under normal conditions, astrocytes remove glutamate from the synaptic cleft and release trophic factors. In addition, these cells determine the functional characteristics of motor neurons. Recent evidence suggests that activation of astrocytes in a degenerative disease like ALS disturbs the crosstalk between astrocytes and motor neurons, which could contribute to and/or accelerate selective motor neuron death. These new insights may contribute to the development of therapeutic approaches to slow this fatal neurodegenerative disease.

Entities:  

Year:  2009        PMID: 19669429      PMCID: PMC2750739          DOI: 10.1007/s10867-009-9141-4

Source DB:  PubMed          Journal:  J Biol Phys        ISSN: 0092-0606            Impact factor:   1.365


  59 in total

1.  AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro.

Authors:  S G Carriedo; S L Sensi; H Z Yin; J H Weiss
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

2.  GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis.

Authors:  Philip Van Damme; Dries Braeken; Geert Callewaert; Wim Robberecht; Ludo Van Den Bosch
Journal:  J Neuropathol Exp Neurol       Date:  2005-07       Impact factor: 3.685

3.  Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.

Authors:  C Bendotti; M Tortarolo; S K Suchak; N Calvaresi; L Carvelli; A Bastone; M Rizzi; M Rattray; T Mennini
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

4.  Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; M Van Kammen; A I Levey; L J Martin; R W Kuncl
Journal:  Ann Neurol       Date:  1995-07       Impact factor: 10.422

5.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

6.  Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis.

Authors:  Mariana Pehar; Patricia Cassina; Marcelo R Vargas; Raquel Castellanos; Liliana Viera; Joseph S Beckman; Alvaro G Estévez; Luis Barbeito
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

7.  The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Philip Van Damme; Maarten Leyssen; Geert Callewaert; Wim Robberecht; Ludo Van Den Bosch
Journal:  Neurosci Lett       Date:  2003-06-05       Impact factor: 3.046

8.  Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.

Authors:  Laia Tolosa; Margalida Mir; Víctor J Asensio; Gabriel Olmos; Jerònia Lladó
Journal:  J Neurochem       Date:  2007-12-25       Impact factor: 5.372

9.  Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria.

Authors:  Lynsey G Bilsland; Niranjanan Nirmalananthan; Jing Yip; Linda Greensmith; Michael R Duchen
Journal:  J Neurochem       Date:  2008-10-25       Impact factor: 5.372

10.  SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.

Authors:  D Trotti; A Rolfs; N C Danbolt; R H Brown; M A Hediger
Journal:  Nat Neurosci       Date:  1999-05       Impact factor: 24.884

View more
  13 in total

1.  TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes.

Authors:  Thomas J LaRocca; Andrea Mariani; Linda R Watkins; Christopher D Link
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

2.  Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders.

Authors:  Alexei Verkhratsky; Vladimir Parpura
Journal:  Neurobiol Dis       Date:  2015-04-03       Impact factor: 5.996

3.  Astroglia in neurological diseases.

Authors:  Alexei Verkhratsky; José J Rodríguez; Vladimir Parpura
Journal:  Future Neurol       Date:  2013-03-01

4.  PATHOBIOLOGY OF NEURODEGENERATION: THE ROLE FOR ASTROGLIA.

Authors:  Alexei Verkhratsky; Robert Zorec; Jose J Rodriguez; Vladimir Parpura
Journal:  Opera Med Physiol       Date:  2016-03-04

Review 5.  Modulators of nucleoside metabolism in the therapy of brain diseases.

Authors:  Detlev Boison
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

6.  Neurological and psychiatric disorders as a neuroglial failure.

Authors:  Alexei Verkhratsky; Vladimir Parpura
Journal:  Period Biol       Date:  2014-07       Impact factor: 0.313

Review 7.  Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.

Authors:  Rachna S Pandya; Haining Zhu; Wei Li; Robert Bowser; Robert M Friedlander; Xin Wang
Journal:  Cell Mol Life Sci       Date:  2013-07-18       Impact factor: 9.261

8.  Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS).

Authors:  Claudia Crosio; Cristiana Valle; Arianna Casciati; Ciro Iaccarino; Maria Teresa Carrì
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 9.  Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.

Authors:  Beihui Liu; Anja G Teschemacher; Sergey Kasparov
Journal:  Glia       Date:  2017-03-16       Impact factor: 7.452

Review 10.  Gliotransmitter Release from Astrocytes: Functional, Developmental, and Pathological Implications in the Brain.

Authors:  Kazuki Harada; Taichi Kamiya; Takashi Tsuboi
Journal:  Front Neurosci       Date:  2016-01-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.